Mid-Illinois Hematology — Normal, Illinois

Mid-Illinois Hematology is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mid-Illinois Hematology has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Illinois Hematology?

Mid-Illinois Hematology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Illinois Hematology conducted?

Mid-Illinois Hematology has 1 clinical trials on record. Their work covers Breast Cancer.

Is Mid-Illinois Hematology accredited by Crixeo Health?

Mid-Illinois Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Illinois Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.